<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01247038</url>
  </required_header>
  <id_info>
    <org_study_id>BMETEU.CR.EU33</org_study_id>
    <secondary_id>Biomet UK Healthcare Ltd</secondary_id>
    <nct_id>NCT01247038</nct_id>
  </id_info>
  <brief_title>A Multicentre Trial to Compare Two Articulating Bearing Surfaces as Used in Cementless Primary Hip Arthroplasty</brief_title>
  <acronym>MagnumCRCT</acronym>
  <official_title>A Multicentre Prospective Randomised Control Trial to Compare Two Articulating Bearing Surfaces, Ceramic on Metal and Metal on Metal Large Diameter Femoral Heads, as Used in Cementless Primary Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to demonstrate the non-inferiority of the ceramic-on-metal&#xD;
      articulation using large diameter bearings (38mm to 60mm) compared to the metal on metal&#xD;
      articulation using the same cup in regards to the composite clinical success (CCS) rate at 2&#xD;
      years postoperatively (delta = 10% minimum clinically significant difference in rates).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This multicentre randomised controlled trial will compare the clinical outcome of the&#xD;
      ceramic-on-metal articulation against a metal-on-metal articulation using the same Recap&#xD;
      Acetabular cup.&#xD;
&#xD;
      The metal ion release will be evaluated at predetermined postoperative intervals during the&#xD;
      first 36 months. A trial will be conducted as a clinical trial in accordance with the Medical&#xD;
      Devices Directive 93/42/EEC (2002).&#xD;
&#xD;
      A total of 150 patients have to be recruited from the South African centre (2 groups)&#xD;
&#xD;
      The initial study assessment period will be 48 months; 24 months recruitment and 24 months&#xD;
      follow-up. The follow-up reviews will be at 6 weeks, 6 months, 1 year, 2 years and 3 years. A&#xD;
      5 year and 10 year clinical review will also be carried out with all patients.&#xD;
&#xD;
      An assessment of incidences of adverse events and metal ion release concentrations will be&#xD;
      made when all patients are at 6 months postoperatively.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Biomet's focus has changed and we no longer expect further developments&#xD;
  </why_stopped>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">July 10, 2015</completion_date>
  <primary_completion_date type="Actual">July 10, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Metal ion concentration in blood and urine</measure>
    <time_frame>2 years post operatively</time_frame>
    <description>Metal ion concentration will be determined from patients blood and urine at prescribed intervals</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite Clinical Score (CCS) rate at 2 years post operative</measure>
    <time_frame>2 years post operatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Metal on ceramic articulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The arm consists of patients with Ceramic femoral heads articulating with metal acetabular cups</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Metal-on-metal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The arm consists of patients with Metal femoral heads articulating with metal acetabular cups</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Metal on ceramic articulation</intervention_name>
    <description>Metal on ceramic articulation against metal-on-metal articulation using the same Recap Acetabular cup</description>
    <arm_group_label>Metal on ceramic articulation</arm_group_label>
    <other_name>MagnumC</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Metal-on-Metal</intervention_name>
    <description>Metal on Metal articulation</description>
    <arm_group_label>Metal-on-metal</arm_group_label>
    <other_name>Magnum</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Primary total hip replacement&#xD;
&#xD;
          -  Patient with degenerative joint disease (inflammatory or non-inflammatory) or any of&#xD;
             the composite diagnoses of osteoarthritis,avascular necrosis, legg perthes, rheumatoid&#xD;
             arthritis, diastrophic variant, fracture of the pelvis, fused hip, slipped capital&#xD;
             epiphysis, subcapital fractures, traumatic arthritis&#xD;
&#xD;
          -  Patients preoperative Harris hip score &lt; 80 points&#xD;
&#xD;
          -  Patients with limited co-morbidity - ASA I - III&#xD;
&#xD;
          -  Patients with normal urea and electrolyte levels and creatinine levels&#xD;
&#xD;
          -  Patients must be able to understand instructions and be willing to return for&#xD;
             follow-up&#xD;
&#xD;
          -  Patients willing to provide blood and urine samples for metal ion analysis at&#xD;
             follow-up&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient preoperative Harris hip score &gt; 80 points&#xD;
&#xD;
          -  Pre-existing metal implants&#xD;
&#xD;
          -  Patients with significant co-morbidity - ASSA IV - V&#xD;
&#xD;
          -  Dementia and inability to understand and follow instructions&#xD;
&#xD;
          -  Neurological conditions affecting movement&#xD;
&#xD;
          -  Women younger than 45 years old&#xD;
&#xD;
          -  Presence of symptomatic arthritis in other lower limb joints&#xD;
&#xD;
          -  Patients requiring smaller than 38mm and larger than 60mm diameter femoral heads&#xD;
&#xD;
          -  Patients taking NSAIDs and / all drugs that will affect bone metabolism&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Orthopaedic Hospital &amp; Rehabilitation Clinic of &quot;Dr Miroslav Zotovic&quot;</name>
      <address>
        <city>Banja Luka</city>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johannesburg Hospital</name>
      <address>
        <city>Parktown</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bosnia and Herzegovina</country>
    <country>South Africa</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <study_first_submitted>November 22, 2010</study_first_submitted>
  <study_first_submitted_qc>November 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2010</study_first_posted>
  <last_update_submitted>June 19, 2017</last_update_submitted>
  <last_update_submitted_qc>June 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

